Hydroxysteroid Dehydrogenases
11-beta-Hydroxysteroid Dehydrogenase Type 1
11-beta-Hydroxysteroid Dehydrogenase Type 2
An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.
17-Hydroxysteroid Dehydrogenases
11-beta-Hydroxysteroid Dehydrogenases
20-Hydroxysteroid Dehydrogenases
Steroid 17-alpha-Hydroxylase
A microsomal cytochrome P450 enzyme that catalyzes the 17-alpha-hydroxylation of progesterone or pregnenolone and subsequent cleavage of the residual two carbons at C17 in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP17 gene, generates precursors for glucocorticoid, androgen, and estrogen synthesis. Defects in CYP17 gene cause congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL) and abnormal sexual differentiation.
3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.
Hydrocortisone
Estradiol Dehydrogenases
Cortisone
Sulfotransferases
Alcohol Oxidoreductases
A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99).
Steroids
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
NAD
A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)
Carbohydrate Dehydrogenases
Liver
Testosterone
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
L-Lactate Dehydrogenase
Androsterone
Alcohol Dehydrogenase
Aldehyde Dehydrogenase
Glyceraldehyde-3-Phosphate Dehydrogenases
Carbenoxolone
Receptors, Mineralocorticoid
20-alpha-Hydroxysteroid Dehydrogenase
High dietary potassium chloride intake augments rat renal mineralocorticoid receptor selectivity via 11beta-hydroxysteroid dehydrogenase. (1/271)
Glucocorticoid access to renal corticosteroid receptors is regulated by 11beta-hydroxysteroid dehydrogenases (11beta-HSDs), converting 11beta-hydroxyglucocorticoids into inactive 11-ketones. This mechanism plays a key role in maintaining normal salt-water homeostasis and blood pressure. To study whether renal cortical proximal and distal tubular 11beta-HSDs are modulated, upon shifting the electrolyte status (and may thereby contribute to adjusting the salt-water homeostasis), rats were treated for 14 days with diets with low (0.058 w/w%), normal (0.58%, which is the KCl content of standard European laboratory rat food) or high (5.8%) potassium chloride content. In proximal tubules, dietary KCl had no effect regarding corticosterone 11beta-oxidation in intact cells as well as 11beta-HSD1 and 11beta-HSD2 protein (Western blotting) and mRNA levels (semi-quantitative RT-PCR). In distal tubules, the low KCl diet also had no effect. However, distal tubules of rats fed the high KCl diet showed increased corticosterone 11beta-oxidation rates (1.6-fold, P<0.01) and 11beta-HSD2 protein (4-fold, P<0.01), whereas 11beta-HSD1 protein was decreased (no longer detected, P<0.05). Distal tubular 11beta-HSD mRNA levels were not changed upon dietary treatment. Our results suggest that upon dietary KCl loading distal tubular mineralocorticoid receptor selectivity for aldosterone is increased because of enhanced corticosterone 11beta-oxidation. This may contribute to the fine-tuning of salt-water homeostasis by the kidney. (+info)Full induction of rat myometrial 11beta-hydroxysteroid dehydrogenase type 1 in late pregnancy is dependent on intrauterine occupancy. (2/271)
The 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD-1) enzyme catalyses the conversion of the biologically inert glucocorticoid 11-dehydrocorticosterone to active corticosterone (11-oxoreductase activity) in vivo, and it is dramatically up-regulated in uterine myometrium in the days leading up to parturition. 11beta-HSD-1 is likely to enhance local concentrations of glucocorticoid within the myometrium and thus facilitate uterine contractility, but the stimulus for the increase in myometrial 11beta-HSD-1 is unknown. The objective of the present study was to test whether the induction of myometrial 11beta-HSD-1 is dependent on uterine occupancy or systemic hormonal signals of late pregnancy. This involved use of a unilateral pregnancy (ULP) model in which the gravid and nongravid uterine horns are both exposed to the normal systemic hormonal milieu of pregnancy. Western blot analysis showed that the 11beta-HSD-1 signal was only partially induced in the nongravid horn of ULP rats on Day 22 of pregnancy (term: Day 23). Moreover, artificial distension of this nongravid horn had no effect on myometrial 11beta-HSD-1 immunoreactivity or bioactivity at either Day 16 or Day 22 of pregnancy. Removal of fetuses and placentas on Day 18 reduced myometrial 11beta-HSD-1 bioactivity 4 days later, and this effect was not overcome by artificial maintenance of uterine distension. In contrast, after fetectomy at Day 18 (i.e., removal of the fetus but not placenta), myometrial 11beta-HSD-1 bioactivity was largely maintained on Day 22, indicative of placental support for myometrial 11beta-HSD-1 over this period. In conclusion, our data show that full induction of myometrial 11beta-HSD-1 expression and associated 11-oxoreductase bioactivity late in rat pregnancy is dependent upon intrauterine occupancy. Although the hormonal milieu of late pregnancy appears to stimulate myometrial 11beta-HSD-1 marginally, full induction clearly requires an additional stimulus. Manipulations involving fetectomy and artificial uterine distension indicate that the placenta provides at least part of this stimulus, but uterine stretch does not appear to play a role. (+info)Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. (3/271)
The aim of the present study was to demonstrate rapid effects of aldosterone on the Na(+)-H(+) exchanger in strips of human vascular vessels and to determine whether 11beta-hydroxysteroid dehydrogenase enzyme (11beta-HSD) could play a protective role in this response, such as that described for the classic type I mineralocorticoid receptor (MR). The activity of 11beta-HSD isoforms 1 and 2 were measured in fetal and adult arteries. Both isoforms are present in adult and fetal vessels. However, a significant difference in the proportion of each isoform was found. Isoform 1 activity (in pmol x min(-1) x 100 mg(-1) protein) was 42+/-5 in fetal vessels and 29+/-2 in adult arteries, and isoform 2 activity was 78+/-7 in fetal and 12+/-2 in adult tissue. The nongenomic effect of aldosterone on Na(+)-H(+) exchanger activity was measured in strips of chorionic and radial uterine arteries loaded with the pH-sensitive dye 2',7'-bis(2-carboxyethyl)-5,6-carboxyfluorescein. Recordings of intracellular pH (pH(i)) were made by videofluorescence microscopy. Aldosterone (0.5 nmol/L) rapidly increased pH(i), with a half-maximal effect between 2 and 3 nmol/L in both fetal and adult vessels. Ethylisopropylamiloride, a specific inhibitor of the Na(+)-H(+) exchanger, inhibited this effect. The hormone-mediated increase in pH(i) was unaffected by spironolactone, a classic antagonist of MR, but was completely blocked by RU28318. Cortisol (up to 1 micromol/L) had no effect on pH(i), but when applied in the presence of carbenoxolone, a dramatic increase in Na(+)-H(+) exchanger activity was evident. The increments on pH(i) for each cortisol concentration were similar to those observed for aldosterone. These findings suggest that vascular 11beta-HSD plays an active role in maintaining the specificity of the rapid effects of aldosterone. (+info)Novel nuclear corticosteroid binding in rat small intestinal epithelia. (4/271)
When small intestinal epithelial cells are incubated with [(3)H]corticosterone, nuclear binding is displaced neither by aldosterone nor RU-28362, suggesting that [(3)H]corticosterone is binding to a site distinct from mineralocorticoid receptor and glucocorticoid receptor. Saturation and Scatchard analysis of nuclear [(3)H]corticosterone binding demonstrate a single saturable binding site with a relatively low affinity (49 nM) and high capacity (5 fmol/microg DNA). Competitive binding assays indicate that this site has a unique steroid binding specificity, which distinguishes it from other steroid receptors. Steroid specificity of nuclear binding mirrors inhibition of the low 11beta-dehydrogenase activity, suggesting that binding may be to an 11beta-hydroxysteroid dehydrogenase (11betaHSD) isoform, although 11betaHSD1 is not present in small intestinal epithelia and 11betaHSD2 does not colocalize intracellularly with the binding site. In summary, a nuclear [(3)H]corticosterone binding site is present in small intestinal epithelia that is distinct from other steroid receptors and shares steroid specificity characteristics with 11betaHSD2 but is distinguishable from the latter by its distinct intracellular localization. (+info)Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity. (5/271)
Peroxisome proliferator-activated receptor-gamma (PPARgamma) has been shown to play an important role in the regulation of expression of a subclass of adipocyte genes and to serve as the molecular target of the thiazolidinedione (TZD) and certain non-TZD antidiabetic agents. Hypercorticosteroidism leads to insulin resistance, a variety of metabolic dysfunctions typically seen in diabetes, and hypertrophy of visceral adipose tissue. In adipocytes, the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD-1) converts inactive cortisone into the active glucocorticoid cortisol and thereby plays an important role in regulating the actions of corticosteroids in adipose tissue. Here, we show that both TZD and non-TZD PPARgamma agonists markedly reduced 11beta-HSD-1 gene expression in 3T3-L1 adipocytes. This diminution correlated with a significant decrease in the ability of the adipocytes to convert cortisone to cortisol. The half-maximal inhibition of 11beta-HSD-1 mRNA expression by the TZD, rosiglitazone, occurred at a concentration that was similar to its K(d) for binding PPARgamma and EC(50) for inducing adipocyte differentiation thereby indicating that this action was PPARgamma-dependent. The time required for the inhibitory action of the TZD was markedly greater for 11beta-HSD-1 gene expression than for leptin, suggesting that these genes may be down-regulated by different molecular mechanisms. Furthermore, whereas regulation of PPARgamma-inducible genes such as phosphoenolpyruvate carboxykinase was maintained when cellular protein synthesis was abrogated, PPARgamma agonist inhibition of 11beta-HSD-1 and leptin gene expression was ablated, thereby supporting the conclusion that PPARgamma affects the down-regulation of 11beta-HSD-1 indirectly. Finally, treatment of diabetic db/db mice with rosiglitazone inhibited expression of 11beta-HSD-1 in adipose tissue. This decrease in enzyme expression correlated with a significant decline in plasma corticosterone levels. In sum, these data indicate that some of the beneficial effects of PPARgamma antidiabetic agents may result, at least in part, from the down-regulation of 11beta-HSD-1 expression in adipose tissue. (+info)Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1. (6/271)
11-beta-hydroxysteroid dehydrogenase type 1 catalyzes the conversion of cortisone to hormonally active cortisol and has been implicated in the pathogenesis of a number of disorders including insulin resistance and obesity. The enzyme is a glycosylated membrane-bound protein that has proved difficult to purify in an active state. Extracted enzyme typically loses the reductase properties seen in intact cells and shows principally dehydrogenase activity. The C-terminal catalytic domain is known to contain a disulfide bond and is located within the lumen of the endoplasmic reticulum, anchored to the membrane by a single N-terminal transmembrane domain. We report here the functional expression of the catalytic domain of the human enzyme, without the transmembrane domain and the extreme N terminus, in Escherichia coli. Moderate levels of soluble active protein were obtained using an N-terminal fusion with thioredoxin and a 6xHis tag. In contrast, the inclusion of a 6xHis tag at the C terminus adversely affected protein solubility and activity. However, the highest levels of active protein were obtained using a construct expressing the untagged catalytic domain. Nonreducing electrophoresis revealed the presence of both monomeric and dimeric disulfide bonded forms; however, mutation of a nonconserved cysteine residue resulted in a recombinant protein with no intermolecular disulfide bonds but full enzymatic activity. Using the optimal combination of plasmid construct and E. coli host strain, the recombinant protein was purified to apparent homogeneity by single step affinity chromatography. The purified protein possessed both dehydrogenase and reductase activities with a K(m) of 1.4 micrometer for cortisol and 9.5 micrometer for cortisone. This study indicates that glycosylation, the N-terminal region including the transmembrane helix, and intermolecular disulfide bonds are not essential for enzyme activity and that expression in bacteria can provide active recombinant protein for future structural and functional studies. (+info)A transgenic model of visceral obesity and the metabolic syndrome. (7/271)
The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11beta hydroxysteroid dehydrogenase type 1 (11beta HSD-1). We created transgenic mice overexpressing 11beta HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11beta HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome. (+info)Correlation between decrease of 11beta-hydroxysteroid dehydrogenase activity and hypokalemia induced by furosemide in rats. (8/271)
AIM: To investigate the correlation between decrease of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) activity and hypokalemia induced by furosemide (Fur) in rats. METHODS: SD rats were given single dose or successive doses of Fur by gavage. The activity of 11beta-HSD was evaluated by measuring the ratio of 11-dehydrocorticosterone (A) and corticosterone (B) in urine and conversion rate of B to A in renal cortex microsome preparation was determined with HPLC. RESULTS: After giving single dose of Fur (40, 100, and 250 mg/kg) or multiple doses of Fur (10, 20, and 100 mg/kg, bid x 20 d), the ratio of A/B was reduced by 29.0 %, 58.6 %, and 60.9 % at 0 - 2 h; 14.4 %, 36.0 %, and 44.9 %, respectively; the conversion rate of B to A was decreased by 29 %, 33 %, and 37 %; 6 %, 17 %, and 23 %, respectively. The serum potassium was significantly reduced by multiple doses of Fur (20 and 100 mg/kg, bid x 20 d) (P < 0.01). The reduction in serum potassium was positively correlated with the lowering of A/B ratio and the conversion of B to A (P < 0.01). CONCLUSION: The inhibition of renal 11beta-HSD activity may be another new biochemical mechanism for hypokalemia induced by Fur. (+info)11 beta-hydroxysteroid dehydrogenase type 2 in mouse aorta - Localization and influence on response to glucocorticoids<...
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. - SCNi
KEE316Hu | ELISA kit for Homo sapiens (Human) 11-Beta-Hydroxysteroid Dehydrogenase Type 3 (HSD11b3) | Homo sapiens (Human) |...
RCSB PDB - 4FAL: Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4...
Tissue-specific dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome |...
11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid...
Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme
Thiazolopyridines Improve Adipocyte Function by Inhibiting 11 Beta-HSD1 Oxoreductase Activity
I2D - Interologous Interaction Database
17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration | Breast Cancer...
RCSB PDB
- 4FAL: Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4...
Contribution of HSD17B12 for estradiol biosynthesis in human breast cancer - omicX
KEGG ORTHOLOGY: K13370
Drop 21 lbs in 21 days with this fat-eating enzyme - Upgraded Health
On-column ligand exchange for structure-based drug design: a case study with human 11[beta]-hydroxysteroid dehydrogenase type 1...
Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNA | Hypertension
11beta hydroxysteroid dehydrogenase type 2 | A non-isotopic method for estimating 11 beta.
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body...
46 XY DISORDERS OF SEXUAL DEVELOPMENT (DSD) CAUSED BY A RARE MUTATION OF THE 17 beta HYDROXYSTEROID DEHYDROGENASE TYPE 3 GENE ...
The role of 11β-hydroxysteroid dehydrogenase type 1 in bile acid homeostasis - edoc
Status of 17β-hydroxysteroid dehydrogenase type 2 (17 | Open-i
The NGFI-B family of transcription factors regulates expression of 3β-hydroxysteroid dehydrogenase type 2 in the human ovary<...
The role of 17 beta-hydroxysteroid dehydrogenases | Semantic Scholar
Human type 10 17 beta-hydroxysteroid dehydrogenase: molecular modelling and substrate docking.
Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid...
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue. - Radcliffe Department of...
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue. - SCNi
Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNANovelty and Significance | Hypertension
11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of...
Structure and function of human 17beta-hydroxysteroid dehydrogenases. - The Arthritis Research UK Centre for Osteoarthritis...
Structure and function of human 17beta-hydroxysteroid dehydrogenases. - Nuffield Department of Orthopaedics, Rheumatology and...
Most recent papers with the keyword Clinical scholarship | Read by QxMD
Plus it
Rationale Rescuing adverse myocardial redesigning can be an unmet clinical goal - Outlook on PI3K/AKT/mTOR inhibition
Inhibitory effect on pig testicular 20 beta-hydroxysteroid de...
BVT Technologies - Page 2 of 6 - PalmSens
hack: Mutation (PS2) - im Preisvergleich - Konsolen-Spiele günstiger kaufen - GamePro
Phenotypic variability and origins of mutations in the gene encoding 3beta-hydroxysteroid dehydrogenase type II. - The Christie...
17β-hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast...
Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes. - The Kennedy Institute of Rheumatology
What does 11-beta-hydroxysteroid dehydrogenases stand for?
Role of glucocorticoid metabolism in bile acid homeostasis
Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain...
JCI -
Welcome
JCI -
Welcome
Theses & Dissertations
APPLIED ERGOGENICS: Dangerous protein drinks? by Jerry Brainum
Connexios Life Sciences Pvt. Ltd.
NSJ Bioreagents | R30817
Stort Valley and Villages Locality Group | NHS East and North Hertfordshire Clinical Commissioning Group
Cortisol
"Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an ... and 5-beta tetrahydrocortisol (5-beta THF), reactions for which 5-alpha reductase and 5-beta-reductase are the rate-limiting ... The cells do not lose all their fight-or-flight override because of interleukin-1's synergism with CRH. Cortisol even has a ... "11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response". Endocrine Reviews. 25 (5 ...
Cortisone reductase deficiency
... beta}-hydroxysteroid dehydrogenase type 1 activity". Endocrinology. 146 (6): 2539-43. doi:10.1210/en.2005-0117. PMID 15774558. ... "Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to ... "Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to ... "Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1". ...
CYP7B1
... possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes". J. Steroid Biochem. Mol. Biol. 104 ( ... "CYP7B generates a selective estrogen receptor beta agonist in human prostate". J. Clin. Endocrinol. Metab. 89 (6): 2928-35. doi ... 316 (1): 158-64. doi:10.1016/j.bbrc.2004.02.029. PMID 15003524. Yau JL, Rasmuson S, Andrew R, Graham M, Noble J, Olsson T, ... "Entrez Gene: CYP7B1 cytochrome P450, family 7, subfamily B, polypeptide 1". Stapleton G, Steel M, Richardson M, Mason JO, Rose ...
Cortisone
Cooper MS, Stewart PM (2009). "11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal ... p. 1. Quirke, Viviane (2005). "Making British Cortisone: Glaxo and the development of Corticosteroids in Britain in the 1950s- ... 2010-11-16. Retrieved July 31, 2013. "Prednisone and other corticosteroids: Balance the risks and benefits". MayoClinic.com. ... It must be converted to cortisol by the action of 11β-Hydroxysteroid dehydrogenase type 1. This primarily happens in the liver ...
Corticosteroid 11-beta-dehydrogenase isozyme 2
2005). "11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response". Endocr. Rev. 25 (5 ... Persu A (2005). "11beta-Hydroxysteroid deshydrogenase: a multi-faceted enzyme". J. Hypertens. 23 (1): 29-31. doi:10.1097/ ... "Entrez Gene: HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2". Geerling, Joel C.; Arthur D. Loewy (September 2009). " ... 1998). "Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess". Am. J. Hum. Genet. 63 ...
11β-Hydroxysteroid dehydrogenase
11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action". Endocrinology. 142 (4): 1371 ... Seckl JR (January 1997). "11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?". Front ... There are two types of 11β-Hydroxysteroid dehydrogenases that control cortisol concentration: HSD-11β Type 1 and HSD-11β Type 2 ... The dehydrogenase activity of a HSD-11β converts a 11beta-hydroxysteroid to the corresponding 11-oxosteroid by reducing NADP+ ...
11β-Hydroxysteroid dehydrogenase type 1
... beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 ... Wake DJ, Walker BR (February 2006). "Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity". Endocrine. 29 (1): ... Agarwal AK (November 2003). "Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I ... "11beta-Hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas". Journal of ...
List of MeSH codes (D08)
3-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.350.100 - 3alpha-hydroxysteroid dehydrogenase (B-specific) MeSH ... myosin type iii MeSH D08.811.277.040.025.525.843 - myosin type iv MeSH D08.811.277.040.025.525.875 - myosin type v MeSH D08.811 ... dopamine beta-hydroxylase MeSH D08.811.682.690.708.392 - fatty acid desaturases MeSH D08.811.682.690.708.392.312 - beta- ... 20-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.400.074 - 20alpha-hydroxysteroid dehydrogenase MeSH D08.811.682.047. ...
H6PD
2003). "Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase ... Ikegwuonu FI, Jefcoate CR (1999). "Evidence for the involvement of the fatty acid and peroxisomal beta-oxidation pathways in ... Beutler E, Morrison M (1968). "Localization and characteristics of hexose 6-phosphate dehydrogenase (glucose dehydrogenase)". J ... "An autosomal glucose-6-phosphate dehydrogenase (hexose-6-phosphate dehydrogenase) polymorphism in human saliva". Hum. Hered. 26 ...
HSD17B11
"17 beta-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells". Endocrinology. 144 (5): 2084-91. doi: ... "Entrez Gene: HSD17B11 hydroxysteroid (17-beta) dehydrogenase 11". Li KX, Smith RE, Krozowski ZS (1999). "Cloning and expression ... Estradiol 17-beta-dehydrogenase 11 is an enzyme that in humans is encoded by the HSD17B11 gene. GRCh38: Ensembl release 89: ... Haeseleer F, Palczewski K (2000). "Short-chain dehydrogenases/reductases in retina". Methods in Enzymology. 316: 372-83. doi: ...
HSD3B2
... the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase ... of type II 3 beta-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3 beta-hydroxysteroid dehydrogenase ... 1992). "Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal ... 1995). "A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt- ...
HSD17B2
Moghrabi N, Head JR, Andersson S (Nov 1997). "Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in ... Oliveira IO, Lhullier C, Brum IS, Spritzer PM (Sep 2003). "Gene expression of type 2 17 beta hydroxysteroid dehydrogenase in ... 17β-Hydroxysteroid dehydrogenase 2 (17β-HSD2) is an enzyme of the 17β-hydroxysteroid dehydrogenase (17β-HSD) family that in ... "The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species". DNA and Cell ...
HSD2 neuron
42 (1): 1-23. doi:10.1016/j.jchemneu.2011.05.003. PMC 3148274. PMID 21605659. Dong, HW; Petrovich, GD; Watts, AG; Swanson, LW ( ... 1115 (1): 54-64. doi:10.1016/j.brainres.2006.07.091. PMID 16935272. Geerling, JC; Kawata, M; Loewy, AD (Jan 20, 2006). " ... Geerling, JC; Engeland, WC; Kawata, M; Loewy, AD (Jan 11, 2006). "Aldosterone target neurons in the nucleus tractus solitarius ... Geerling, JC; Loewy, AD (Aug 1, 2006). "Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional ...
List of diseases (0-9)
... type 2 deficiency 17 alpha hydroxylase deficiency 17 beta hydroxysteroide dehydrogenase deficiency 17-beta-hydroxysteroid ... type 3, rare (NIH) 3 beta hydroxysteroid dehydrogenase deficiency 3 hydroxyisobutyric aciduria 3 hydroxyisobutyric aciduria, ... dehydrogenase deficiency, rare (NIH) 17q21.31 microdeletion syndrome 18-Hydroxylase deficiency, rare (NIH) 18p deletion ... 3 methylglutaconyl coa hydratase deficiency 3-hydroxy 3-methyl glutaryl-coa lyase deficiency 3-hydroxyacyl-coa dehydrogenase ...
17β-Hydroxysteroid dehydrogenase
3(or+17)beta-hydroxysteroid+dehydrogenase at the US National Library of Medicine Medical Subject Headings (MeSH) Portal: ... Soubhye J, Alard IC, van Antwerpen P, Dufrasne F (2015). "Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the ... Yang SY, He XY, Isaacs C, Dobkin C, Miller D, Philipp M (2014). "Roles of 17β-hydroxysteroid dehydrogenase type 10 in ... Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX (April 2010). "17beta-hydroxysteroid dehydrogenase type 1 stimulates breast ...
AKR1C3
Rheault P, Dufort I, Soucy P, Luu-The V (1999). "Assignment of HSD17B5 encoding type 5 17 beta-hydroxysteroid dehydrogenase to ... 3-alpha hydroxysteroid dehydrogenase, type II)". Theisen, J. Graham; Sundaram, Viji; Filchak, Mary S.; Chorich, Lynn P.; ... also known as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5, HSD17B5) is a key steroidogenic enzyme that in humans is ... "Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5". Molecular and ...
HSD17B1
... estradiols having inhibitory effect on human placental estradiol 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD type 1)". ... "Entrez Gene: HSD17B1 Hydroxysteroid (17-beta) dehydrogenase 1". Saloniemi T, Jokela H, Strauss L, Pakarinen P, Poutanen M (2012 ... Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX (Apr 2010). "17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer ... Sawetawan C, Milewich L, Word RA, Carr BR, Rainey WE (Mar 1994). "Compartmentalization of type I 17 beta-hydroxysteroid ...
Mineralocorticoid
This type of receptor becomes activated upon ligand binding. After a hormone binds to the corresponding receptor, the newly ... 1 (1). doi:10.15347/wjm/2014.005. ISSN 2002-4436. Omar, HR; Komarova, I; El-Ghonemi, M; Fathy, A; Rashad, R; Abdelmalak, HD; ... This enzyme, 11-beta hydroxysteroid dehydrogenase type II (Protein:HSD11B2), catalyzes the deactivation of glucocorticoids to ... 11 ed)., Saunders Elsevier, Philadelphia, pp. 445-504. Bennett PN and Brown MJ (2008) "Adrenal corticosteroids, antagonists, ...
11α-Hydroxyprogesterone
Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue". Steroids. 62 (1): 77-82 ... 11α-OHP is a more potent inhibitor of 11β-HSD than enoxolone (glycyrrhetinic acid) or carbenoxolone in vitro (IC50 = 0.9 nM; ... 11 alpha-Hydroxyprogesterone (11 alpha OH-P) was an order of magnitude more potent a competitive inhibitor of the 11 beta HSD-2 ... 11α-OHP was investigated as a topical antiandrogen for the treatment of androgen-dependent skin conditions in the early 1950s, ...
17β-Hydroxysteroid dehydrogenase III deficiency
... metabolism Disorders of sexual development Intersex 17β-Hydroxysteroid dehydrogenase 17β-Hydroxysteroid dehydrogenase Type III ... "HSD17B3 hydroxysteroid 17-beta dehydrogenase 3 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-03- ... "17-beta hydroxysteroid dehydrogenase 3 deficiency , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". ... "17-beta hydroxysteroid dehydrogenase 3 deficiency". Genetics Home Reference. Retrieved 2017-03-11. "OMIM Entry - # 264300 - 17- ...
HSD3B1
"Polymorphism in exon 4 of the human 3 beta-hydroxysteroid dehydrogenase type I gene (HSD3B1) and blood pressure". Biochemical ... "Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the ... "Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in ... HSD3B1 is a human gene that encodes for a 3beta-hydroxysteroid dehydrogenase/delta(5)-delta(4)isomerase type I or hydroxy-delta ...
Pharmacodynamics of spironolactone
Soubhye J, Alard IC, van Antwerpen P, Dufrasne F (2015). "Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the ... Sam KM, Auger S, Luu-The V, Poirier D (1995). "Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase ... Poirier D (2003). "Inhibitors of 17 beta-hydroxysteroid dehydrogenases". Curr. Med. Chem. 10 (6): 453-77. doi:10.2174/ ... "Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding ...
HSD17B10
"Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model". Brain Research. ... 17-β-Hydroxysteroid dehydrogenase X (HSD10) also known as 3-hydroxyacyl-CoA dehydrogenase type-2 is a mitochondrial enzyme that ... 17-beta) dehydrogenase 10". He XY, Yang YZ, Schulz H, Yang SY (Jan 2000). "Intrinsic alcohol dehydrogenase and hydroxysteroid ... Yang SY, He XY, Isaacs C, Dobkin C, Miller D, Philipp M (Sep 2014). "Roles of 17β-hydroxysteroid dehydrogenase type 10 in ...
Hyperaldosteronism
... type I (dexamethasone suppressible), and type II, which has been linked to the 7p22 gene. Features Hypertension Hypokalemia (e. ... November 2000). "A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 ( ... 37 (11): 831-5. doi:10.1136/jmg.37.11.831. PMC 1734468. PMID 11073536. Dominguez A, Muppidi V, Gupta S. "Hyperaldosteronism". ... Through inhibition of 11-beta-hydroxysteroid dehydrogenase type 2 (11-beta-HSD2), glycyrrhizin allows cortisol to activate ...
DHRS7B
Dehydrogenase/reductase (SDR family) member 7B is an enzyme encoded by the DHRS7B gene in humans, found on chromosome 17p11.2. ... CD44 is an antigen found on the surface of most cell types and functions as a receptor that binds tissue macromolecules. ... "Entrez Gene: Dehydrogenase/reductase (SDR family) member 7B". "Genecards: DHRS7B Gene protein-coding GIFtS 47". Tannin GM, ... DHRS7B is a member of the short chain dehydrogenase/reductase (SDR) superfamily and possesses characteristic features of an SDR ...
Ugonjwa wa Cushing, kamusi elezo huru
testicular: enzymatic (5-alpha-reductase deficiency, 17-beta-hydroxysteroid dehydrogenase deficiency) · Androgen receptor ( ... types: (type 1, type 2, MODY 1 2 3 4 5 6) · complications (coma, angiopathy, ketoacidosis, nephropathy, neuropathy, retinopathy ... 11] Epidemiolojia[hariri , hariri chanzo]. Ugonjwa wa Cushing wa iatrojeniki (unaosababishwa na matibabu kwa kutumia steroidi ... Autoimmune polyendocrine syndrome (APS1, APS2) · Carcinoid syndrome · Multiple endocrine neoplasia (1, 2A, 2B) · Progeria ( ...
List of diseases (C)
... adrenal hyperplasia due to 21-hydroxylase deficiency Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase ... CDG syndrome type 1A CDG syndrome type 1B CDG syndrome type 1C CDG syndrome type 2 CDG syndrome type 3 CDG syndrome type 4 CDK4 ... Tooth disease type 1C Charcot-Marie-Tooth disease type 2A Charcot-Marie-Tooth disease type 2B1 Charcot-Marie-Tooth disease type ... disease type 2C Charcot-Marie-Tooth disease type 2D Charcot-Marie-Tooth disease type 4A Charcot-Marie-Tooth disease type 4B ...
Interleukin 3
... in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine". J ... It is thought that this genetic change is the key in development of this leukemia type. Human IL-3 was first cloned in 1986 and ... Kitamura T, Sato N, Arai K, Miyajima A (1991). "Expression cloning of the human IL-3 receptor cDNA reveals a shared beta ... IL-3 is mainly produced by activated T cells with the goal of initiating proliferation of various other immune cell types. ...
List of OMIM disorder codes
CYP17A1 17-beta-hydroxysteroid dehydrogenase X deficiency; 300438; HSD17B10 2-methylbutyrylglycinuria; 610006; ACADSB 3- ... type 1B; 276900; MYO7A Usher syndrome, type 1C; 276904; USH1C Usher syndrome, type 1D; 601067; CDH23 Usher syndrome, type 1D/F ... F5 Factor XI deficiency, autosomal dominant; 612416; F11 Factor XI deficiency, autosomal recessive; 612416; F11 Factor XII ... type I; 125850; HNF4A MODY, type II; 125851; GCK MODY, type III; 600496; HNF1A MODY, type IV; 606392; IPF1 Mohr-Tranebjærg ...
Methylprednisolone
Osteoporosis is a type of bone disease characterized by a loss of bone density, mass and architecture that leaves a patient ... beta]-hydroxy-20[alpha]-hydroxymethylprednisolone. As stated previously, the primary use of methylprednisolone is to suppress ... The prevalence of mGRs ranges per cell type, with the highest concentration in B lymphocytes at up to 12.3%, up to 9.2% in ... The type and severity of neuropsychiatric symptoms also varies significantly between patients, with 33% of patients reporting ...
Genetic studies on Arabs
Rosler A (August 2006). "17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population". Pediatric ... Bare lymphocyte syndrome high in western Arabic block Morocco, type II limb-girdle muscular dystrophy, type 2C in Libya, ... Jerash type of the distal hereditary motor neuropathy (2000) •• Karak syndrome (2003) •• Omani type of spondyloepiphy Below is ... Lebanese type of mannose 6--phosphate receptor recognition defect (1984) •• Algerian type of spondylometaphyseal dysplasia ( ...
Transferase
Type A (express A antigens), Type B (express B antigens), Type AB (express both A and B antigens) and Type O (express neither A ... Herbst EA, MacPherson RE, LeBlanc PJ, Roy BD, Jeoung NH, Harris RA, Peters SJ (Jan 2014). "Pyruvate dehydrogenase kinase-4 ... Due to this, alcohol sulfotransferase is also known by several other names including "hydroxysteroid sulfotransferase," " ... Earliest discoveries of transferase activity occurred in other classifications of enzymes, including beta-galactosidase, ...
HSD17B8
"Entrez Gene: HSD17B8 hydroxysteroid (17-beta) dehydrogenase 8". Kikuti YY, Tamiya G, Ando A, et al. (1997). "Physical mapping ... 2007). "Transcriptional regulation of the human type 8 17beta-hydroxysteroid dehydrogenase gene by C/EBPbeta". J. Steroid ... In mice, the Ke6 protein is a 17-beta-hydroxysteroid dehydrogenase that can regulate the concentration of biologically active ... 2006). "Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An ...
Liver receptor homolog-1
... in the regulation of human corpus luteum 3beta-hydroxysteroid dehydrogenase type II". The Journal of Clinical Endocrinology and ... LRH-1 is a member of the nuclear receptor family of intracellular transcription factors. LRH-1 plays a critical role in the ... 5 (1): 1-2. doi:10.1016/S1534-5807(03)00196-5. PMID 12852843. Fayard E, Schoonjans K, Annicotte JS, Auwerx J (Sep 2003). "Liver ... Cai YN, Zhou Q, Kong YY, Li M, Viollet B, Xie YH, Wang Y (Dec 2003). "LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis ...
Estriol
Then, 16α-OH-DHEA is converted by 3β-hydroxysteroid dehydrogenase type I (3β-HSD1) into 16α-hydroxyandrostenedione (16α-OH-A4) ... "Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta". Biochemical ... DHEA is converted by 3β-hydroxysteroid dehydrogenase type I into androstenedione, and androstenedione is aromatized into ... Then, placental 17β-hydroxysteroid dehydrogenase interconverts estrone and estradiol and the two hormones are secreted into the ...
Pharmacodynamics of estradiol
This is due to its inability to be inactivated by uterine 17β-hydroxysteroid dehydrogenase (17β-HSD). Because of its ... Type of aqueous (solution or suspension) was not specified. Testosterone levels in relation to estradiol levels (and ... Lobo RA, Cassidenti DL (January 1992). "Pharmacokinetics of oral 17 beta-estradiol". J Reprod Med. 37 (1): 77-84. PMID 1548642 ... As a result of the alkylation in 17-C position it is not a substrate for 17β dehydrogenase, an enzyme which transforms natural ...
Steroidogenesis inhibitor
3β-Hydroxysteroid dehydrogenase (3β-HSD) inhibitors such as amphenone B, azastene, cyanoketone, epostane, mitotane, and ... Schroepfer GJ, Parish EJ, Kisic A, Jackson EM, Farley CM, Mott GE (1982). "5 alpha-Cholest-8(14)-en-3 beta-ol-15-one, a potent ... A steroidogenesis inhibitor, also known as a steroid biosynthesis inhibitor, is a type of drug which inhibits one or more of ... 17β-Hydroxysteroid dehydrogenase (17β-HSD) inhibitors prevent the reversible conversion of the weak androgens ...
Testosterone
In the final and rate limiting step, the C17 keto group androstenedione is reduced by 17β-hydroxysteroid dehydrogenase to yield ... These include adult-type body odor, increased oiliness of skin and hair, acne, pubarche (appearance of pubic hair), axillary ... In addition, the 3β-hydroxyl group is oxidized by 3β-hydroxysteroid dehydrogenase to produce androstenedione. ... 3α-hydroxysteroid dehydrogenase, and 17β-HSD, in that order. Androsterone and etiocholanolone are then glucuronidated and to a ...
Coumestrol
... allowing it to inhibit the activity of aromatase and 3α-hydroxysteroid dehydrogenase. These enzymes are involved in the ... The highest concentrations of coumestrol are found in clover, Kala Chana (a type of chick pea), and Alfalfa sprouts. Coumestrol ... "Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta". ... 3α-Hydroxysteroid dehydrogenase inhibitors, Aromatase inhibitors, Coumestans, Phytoestrogens, Selective ERβ agonists, Phenols) ...
Rosiglitazone
3β-Hydroxysteroid dehydrogenase inhibitors, CYP17A1 inhibitors, Hepatotoxins, Thiazolidinediones, Aminopyridines, Phenol ethers ... It doubled the risk of fractures among women with type 2 diabetes, without a significant increase in risk of fractures among ... It is also found in pancreatic beta cells, vascular endothelium, and macrophages Rosiglitazone is a selective ligand of PPARγ ... Investigators from the Cochrane Collaboration published a meta-analysis of their own on the use of rosiglitazone in Type II ...
Adrenal gland
Enzymes involved in this process include both mitochondrial and microsomal P450s and hydroxysteroid dehydrogenases. Usually a ... This type of adrenal insufficiency usually does not affect the production of mineralocorticoids, which are under regulation of ... The central adrenomedullary vein, in the adrenal medulla, is an unusual type of blood vessel. Its structure is different from ... The adrenal glands are composed of two heterogenous types of tissue. In the center is the adrenal medulla, which produces ...
Mineralocorticoid receptor
Zennaro MC, Farman N, Bonvalet JP, Lombès M (May 1997). "Tissue-specific expression of alpha and beta messenger ribonucleic ... "Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I". Nature Genetics. 19 ... 52 (1-2): 83-4. doi:10.1159/000132846. PMID 2558856. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, et al. ( ... 85 (1): 130-2. doi:10.1007/BF00276340. PMID 2162806. S2CID 9264993. Fan YS, Eddy RL, Byers MG, Haley LL, Henry WM, Nowak NJ, ...
Formebolone
17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds". Steroids. 43 (3): 271-82. doi:10.1016/0039-128x(84) ... beta)-diol-3-one) in humans". J. Int. Med. Res. 4 (2): 96-105. doi:10.1177/030006057600400203. PMID 799985. S2CID 86157607. ... 27 (3 Pt 1): 421-5. doi:10.1161/01.hyp.27.3.421. PMID 8698448. Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M ... 577-. ISBN 978-1-4757-2085-3. I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: ...
Roxibolone
17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds". Steroids. 43 (3): 271-82. doi:10.1016/0039-128x(84) ... 27 (3 Pt 1): 421-5. doi:10.1161/01.hyp.27.3.421. PMID 8698448. Fürstenberger C, Vuorinen A, Da Cunha T, Kratschmar DV, Saugy M ... In accordance, 11α- and 11β-hydroxyprogesterone are known to be potent inhibitors of 11β-hydroxysteroid dehydrogenase (11β-HSD ... ISBN 978-1-4757-2085-3. Felippone F, Resnati G, Scolastico C, Tronconi G (1984). "Synthesis of 2-carboxy-11 beta, ...
Progesterone
Subsequently, 20α-hydroxysteroid dehydrogenase and 20β-hydroxysteroid dehydrogenase reduce these metabolites to form the ... Collaborative Group on Hormonal Factors in Breast Cancer (September 2019). "Type and timing of menopausal hormone therapy and ... "Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation". Proceedings of ... This is followed by the further reduction of these metabolites via 3α-hydroxysteroid dehydrogenase and 3β-hydroxysteroid ...
Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1. - The Kennedy Institute of Rheumatology
11beta-HSD) catalyzes the reversible oxidoreduction of 11beta-OH/11-oxo groups of glucocorticoid hormones. Besides this ... Purified recombinant 11beta-HSD1 mediated oxidative reactions, however, the labile reductive activity component could not be ... In conclusion, evidence is provided that human 11beta-HSD1 in vitro is involved in phase I reactions of anti-inflammatory non- ... The aim of this study was to explore novel substrate specificities of human 11beta-HSD1, using heterologously expressed protein ...
Human HSD11b1(11-Beta-Hydroxysteroid Dehydrogenase Type 1) ELISA Kit - LipidX
Human ALDH1A2(Aldehyde Dehydrogenase 1 Family, Member A2) ELISA Kit. *Human ALDOC(Aldolase C, Fructose Bisphosphate) ELISA Kit ... Human PCSK5(Proprotein Convertase Subtilisin/Kexin Type 5) ELISA Kit. *Human PDCD1LG1(Programmed Cell Death Protein 1 Ligand 1 ... Human ALDH1A1(Aldehyde Dehydrogenase 1 Family, Member A1) ELISA Kit. * ... Human CELSR2(Cadherin EGF LAG Seven Pass G-Type Receptor 2) ELISA Kit ...
11 beta-hydroxysteroid dehydrogenase type 1 in obese children - Radcliffe Department of Medicine
11β-Hydroxysteroid dehydrogenase type 1 - Wikipedia
... beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 ... Wake DJ, Walker BR (February 2006). "Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity". Endocrine. 29 (1): ... Agarwal AK (November 2003). "Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I ... "11beta-Hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas". Journal of ...
Abstracts | 0007 | BES2004 | 23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine...
The impact of endogenous cortisone on bone and fat: demonstration of in vivo 11beta-hydroxysteroid dehydrogenase type 1 ... Analysis of hCG beta core fragment glycosylation in normal and aberrant pregnancy by matrix-assisted laser desorption/ ... A novel non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of metabolic syndrome in murine ... A model for evaluating 11beta-hydroxysteroid dehydrogenase type 1 activity in ocular and orbital tissues ...
Tetrahydrocortisone | Semantic Scholar
11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. ... Product OverviewBeta ProgramS2AG APISemantic Reader. Research. PublicationsTeamResearch CareersResources ... Apparent mineralocorticoid excess: Type I and type II. *F. Mantero, M. Palermo, M. Petrelli, R. Tedde, P. Stewart, C. ... hydroxysteroid dehydrogenase (11β‐HSD) catalyse the interconversion of cortisol to hormonally… Expand. ...
Current Therapies and Emerging Drugs in the Pipeline for Type 2 Diabetes
The 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor is an enzyme that converts the inert hormone cortisone ... 44 Using a model involving GPR119 beta-cell-expressing mice with type 2 diabetes, the investigators demonstrated a significant ... Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Disc Today. 2007;12:504-520. ... Effects of the 11beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone in insulin sensitivity in men with type 2 diabetes. ...
Antibodies, ELISA Kits, Research Products - Gentaur.com
01023629837Interleukin-1 beta (IL-1β) ELISA Kit, 96-wellInfo Anogen EL10028 96-well890.26Ask ... 0401248752511-Beta-Hydroxysteroid Dehydrogenase Type 1 (HSD11b1) Polyclonal AntibodyInfo bioma CAU24477 200 μg1167.30Ask ... 01011986799anti-Human IgM (µ) -FITC (F(ab)2 Fragment) w/ counterstain - 3 mlInfo virusys AG041 1 item202.33Ask ... 01013807852Total Protein Extraction Kit (for Animal Cultured Cells and Tissues)Info Inventbiotech SN-002 1 kit/50 reactions ...
Characterization of Novel StAR (Steroidogenic Acute Regulatory Protein) Mutations Causing Non-Classic Lipoid Adrenal...
Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences ... In our simulation, E169, R188, H220, T223 and S244 located on the beta sheets of the cholesterol binding cavity next to helix 3 ... However, only ∼25% of such patients were found to be the carriers of MC2R mutations and have been classified as type 1 FGD [7] ... Vectors expressing cDNAs of wild-type (wt) StAR and the fusion protein P450 side-chain cleavage/adrenodoxin/adrenodoxin ...
Kenalog-10, Kenalog-40 (triamcinolone acetonide injectable suspension) dosing, indications, interactions, adverse effects, and...
adenovirus types 4 and 7 live, oral. triamcinolone acetonide injectable suspension decreases effects of adenovirus types 4 and ... adenovirus types 4 and 7 live, oral. Serious - Use Alternative (1)triamcinolone acetonide injectable suspension decreases ... haemophilus influenzae type b vaccine. Monitor Closely (1)triamcinolone acetonide injectable suspension decreases effects of ... haemophilus influenzae type b vaccine. triamcinolone acetonide injectable suspension decreases effects of haemophilus ...
obesity enzyme Anne Collins
To test this hypothesis, Flier and his colleagues studied the enzyme 11beta hydroxysteroid dehydrogenase type 1 (11 beta HSD-1 ... US Obesity-Related Costs (Annual) Obesity Related Disease Costs Overwhelm HealthCare System Type II Diabetes ($63.14… Read More ... The researchers created a group of transgenic (Tg) mice that overproduce 11 beta HSD-1 in roughly the same quantities ... the findings strongly suggest that the 11 beta HSD-1 enzyme is an exciting pharmaceutical target for the treatment of visceral ...
Human KEAP1(kelch-like ECH-associated protein 1) ELISA Kit, Cat#EKF59003 - Biomatik
Product/Service Type: ELISA Kits. *Immunity, 50(2): 446-461.e9. (2019). PMID: 30709742. Title: Microbiota Sensing by Mincle-Syk ... Bovine bLg / Beta-Lactoglobulin ELISA Kit, Cat#EKN43818 Quick view Wishlist Bovine bLg / Beta-Lactoglobulin ELISA Kit, Cat# ... Product/Service Type: Custom Gene Synthesis Service. *Nature, 577: 689-694. (2020). PMID: 31942068. Title: VEGF-C-driven ... Product/Service Type: Custom Peptide Synthesis Service. *Neuron, 102(2): 420-434.e8. (2019). PMID: 30826183. Title: Distinct ...
Prednisolone phosphate: Uses, Interactions, Mechanism of Action | DrugBank Online
11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic ... Catalyzes reversibly the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. In intact cells, the rea.... Gene Name. ... 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic ... SummaryBrand NamesNameAccession NumberBackgroundTypeGroupsStructureWeightChemical FormulaSynonyms ...
Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. - SCNi
... and water reabsorption is mediated by 11beta-hydroxysteroid dehydrogenase type 2 that protects the mineralocorticoid receptor ... 11beta-HSD type 1 (11beta-HSD1), that generates intraocular cortisol. In a mechanism analogous to that of the embryologically ... an 11beta-HSD inhibitor). Using the real time-polymerase chain reaction, rabbit CP tissue was found to express levels of 11beta ... Expression of 11beta-HSD1 may be fundamental in the regulation of CSF secretion and the local generation of cortisol may ...
Spot Reduction Revisited: Removing Stubborn Thigh Fat - The Blog of Author Tim Ferriss
2 - Via inhibition of 11beta-hydroxysteroid dehydrogenase type 1.. 3 - All measurements were taken at least three times and ... You want a the highest concentration of beta waves in that part of the brain. In clients with low F3/C3 beta activity, I see a ... Im typing into my Evernote (Slow carb "rules," Occams routine, various instructional bits from the book that I might want to ... I agree with Katie regarding the type of diet you should follow. As someone who has trained a lot, at one point I had a bodyfat ...
bioassay - Gentaur shop
Horse Beta-Endorphin,β-EP ELISA Kit. 96T. 822€. Details. E0027HO. Horse Brain natriureti peptide(BNP)ELISA Kit. 96T. 822€. ... Horse Retinal dehydrogenase 1,ALDH1A1 ELISA Kit. 96T. 822€. Details. E0031HO. Horse Serum amyloid A(SAA)ELISA Kit. 96T. 822€. ... Horse Hemoglobin subunit beta(HBB) ELISA Kit. 96T. 822€. Details. E0009HO. Horse Hyaluronic acid,HA ELISA Kit. 96T. 822€. ... Human 11-Deoxycortisol ELISA Kit. 96T. 634€. Details. E3107Hu. Human 11-keto Testosterone(11-KETO-T) ELISA Kit. 96T. 634€. ...
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy | Life Science Alliance
2002) 11beta-hydroxysteroid dehydrogenase types 1 and 2: An important pharmacokinetic determinant for the activity of synthetic ... 2009) Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest 119: 3703-3712. doi:10.1172/jci39845 ... In wild-type mice, the only effect observed for aldosterone was a smaller increase in LV mass (P , 0.05), which was similar to ... Wild-type (strain 000476; C57BL/10ScSnJ) and mdx (strain 001801; C57BL/10ScSn-Dmdmdx/J) mice were obtained from The Jackson ...
Corticotropin-releasing hormone stimulates expression of leptin, 11beta-HSD2 and syncytin-1 in primary human trophoblasts |...
The expression of the IUGR marker genes leptin and 11beta-hydroxysteroid dehydrogenase 2 (11beta-HSD2) was measured ... CRH did not influence the differentiation of isolated trophoblasts into functional syncytium as determined by beta-hCG ... The induction of leptin and 11beta-HSD2 in the syncytiotrophoblast by CRH might promote fetal nutrient supply and placental ... Following syncytialisation, CRH treatment significantly increased leptin and 11beta-HSD2 expression, as well as leptin ...
Anti-Estrogen Receptor beta antibody [14C8] (GTX70174) | GeneTex
Mouse Monoclonal Estrogen Receptor beta antibody [14C8]. Validated in WB, ICC/IF, IHC-P, IHC-Fr, FACS, Dot, ChIP assay, IHC, ... 167 Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent ... PLoS One 2009; 4 (7):e6271 Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta- ... Estrogen Receptor beta stained by Estrogen Receptor beta antibody [14C8] (GTX70174) diluted at 1:200.. Antigen Retrieval: ...
Fyziologický ústav AV ČR - Funkce epitelu
34, 1, p. 1-16 . IF = 2.643 [ASEP] [ doi ] Ergang, Peter - Vodička, Martin - Vagnerová, Karla - Moravec, Martin - Kvapilová, ... 2020; 10(1)); 8529 . IF = 4.379 [ASEP] [ doi ] Vodička; Martin - Vavřínová; Anna - Mikulecká; Anna - Zicha; Josef - Behuliak; ... Regulation of 11 beta-Hydroxysteroid Dehydrogenase Type 1 and 7 alpha-Hydroxylase CYP7B1 during Social Stress . PLoS ONE 2014, ... Expression of 11 beta-hydroxysteroid dehydrogenase type 2 is deregulated in colon carcinoma . Histology and Histopathology 2014 ...
HuGE Navigator|HuGE Literature Finder|PHGKB
Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population. ... beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. European journal of ... Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with ... Relationship of 11ß-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic ...
Pseudo-Cushing Syndrome: Overview, Causes and Complications, History and Physical Examination
11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients ... pseudo-Cushings syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 ... A particular type of hypercortisolism presenting during the above conditions, named functional hypercortisolism, is caused by ... 15] In a study of 190 patients with type 2 diabetes, 63 subjects (33%) had high cortisol concentrations. [16] ...
Egrifta (tesamorelin) dosing, indications, interactions, adverse effects, and more.
Reconstitute second 1-mg vial. *Reconstitute the second 1-mg vial with the entire solution from the first reconstituted vial ... Serious - Use Alternative (1)tesamorelin will decrease the level or effect of cortisone by altering metabolism. Avoid or Use ... Serious - Use Alternative (1)tesamorelin will decrease the level or effect of prednisone by altering metabolism. Avoid or Use ... Serious - Use Alternative (1)tesamorelin will decrease the level or effect of ulipristal by altering metabolism. Avoid or Use ...
11βhydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: Implications in obesity and...
However, D7 cortisol enrichment was detectable in abdominal sc fat of overweight/obese participants with type 2 diabetes ... However, D7 cortisol enrichment was detectable in abdominal sc fat of overweight/obese participants with type 2 diabetes ... However, D7 cortisol enrichment was detectable in abdominal sc fat of overweight/obese participants with type 2 diabetes ... However, D7 cortisol enrichment was detectable in abdominal sc fat of overweight/obese participants with type 2 diabetes ...
PrimoJect for sale - Order Anabolic Steroids Cheap
Do Legal Steroids not show similar fiber type and improved energy. Doctor and pharmacist of all users with the Revised Male ... Week 1-12: Test Cypionate association of endogenous testosterone know as much as possible because steroids do have all kinds of ... 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD-1) required for many physical and discover everything you need to know ...
Hyperkalemia: Practice Essentials, Background, Pathophysiology
3-beta hydroxysteroid dehydrogenase deficiency, and 17 alpha-hydroxylase/17,20-lyase deficiency are generally not characterized ... Type 1 GFND maps to chromosome 1q32, but the gene is unknown at this time. Type 2 GFND is caused by mutations in the FN1 gene ... Beta-adrenergic agonists enhance potassium entry into cells, whereas beta-blockers and alpha-adrenergic agonists inhibit it. ... Type I pseudohypoaldosteronism (PHAI) can be caused by an inactivating mutation of 1 of 3 encoding subunits of the epithelial ...
Hyperkalemia: Practice Essentials, Background, Pathophysiology
3-beta hydroxysteroid dehydrogenase deficiency, and 17 alpha-hydroxylase/17,20-lyase deficiency are generally not characterized ... Type 1 GFND maps to chromosome 1q32, but the gene is unknown at this time. Type 2 GFND is caused by mutations in the FN1 gene ... Beta-adrenergic agonists enhance potassium entry into cells, whereas beta-blockers and alpha-adrenergic agonists inhibit it. ... Type I pseudohypoaldosteronism (PHAI) can be caused by an inactivating mutation of 1 of 3 encoding subunits of the epithelial ...
Speakers | Insulin 100
... identifying the liver as a major site of extra-adrenal cortisol production via intrahepatic 11beta-hydroxysteroid dehydrogenase ... His research focuses on the molecular mechanisms regulating insulitis and beta cell apoptosis in type 1 diabetes and on the ... Recorded Presentation Title: Therapy of Type 1 Diabetes: The DCCT-EDIC Trials. Live Discussion: April 16, 1030-1110 [EDT]. Dr. ... Recorded Presentation Title: A Primary Role for Insulin Therapy in Type 2 Diabetes. Live Discussion: April 15, 0940-1020. Dr. ...
Enzyme 11beta-hydroxysteroiHSD11b1CortisoneInhibitorsHexose-6-phosphate dehydrogenaseELISA KitMetabolismShort-chain dehydrogenasesSteroidInhibitsInhibitionProteinGlucocorticoid2019ObeseTestosteroneCorticosteroidsIsozymeEnzymesKidneyGenesCONGENITALMiceInhibitorActivityCorticosteroneSyndromePathwaysReceptorGeneticGene Expression2018InsulinMutationsVasodilationSecretionSynthesisEndocrineHumanMales
Enzyme 11beta-hydroxysteroi3
- The human enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD) catalyzes the reversible oxidoreduction of 11beta-OH/11-oxo groups of glucocorticoid hormones. (ox.ac.uk)
- To test this hypothesis, Flier and his colleagues studied the enzyme 11beta hydroxysteroid dehydrogenase type 1 (11 beta HSD-1), which has the unique ability to produce cortisol in cells that are not normally associated with cortisol production. (annecollins.com)
- The enzyme 11beta-hydroxysteroid dehydrogenase (11B-HSD) reversibly converts biologically active cortisol to inactive cortisone, and when present in placentae may act to protect fetuses from high concentrations of maternal glucocorticoids. (usda.gov)
HSD11b16
- Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human 11-Beta-Hydroxysteroid Dehydrogenase Type 1 (HSD11b1) in tissue homogenates, cell lysates and other biological fluids. (lipidx.org)
- Variants in HSD11B1 gene modulate susceptibility to diabetes kidney disease and to insulin resistance in type 1 diabetes. (cdc.gov)
- Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional study. (cdc.gov)
- Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population. (cdc.gov)
- Association of HSD11B1 polymorphic variants and adipose tissue gene expression with metabolic syndrome, obesity and type 2 diabetes mellitus: a systematic review. (cdc.gov)
- A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. (cdc.gov)
Cortisone10
- 11β-Hydroxysteroid dehydrogenase type 1, also known as cortisone reductase, is an NADPH-dependent enzyme highly expressed in key metabolic tissues including liver, adipose tissue, and the central nervous system. (wikipedia.org)
- This is opposite to classical Na(+) transporting tissues, such as the kidney, where Na(+) and water reabsorption is mediated by 11beta-hydroxysteroid dehydrogenase type 2 that protects the mineralocorticoid receptor by abrogating active cortisol to inactive cortisone. (ox.ac.uk)
- [ 22 , 23 ] In obesity, postulated mechanisms of hyperactivation of HPA axis include hyper-responsiveness to different neuropeptides, stress events, dietary factors, as well as a stimulation caused by augmented peripheral metabolism and clearance of cortisol by reduced conversion of cortisone to cortisol by 11β-HSD1 and increased conversion of cortisol to 5α-reduced derivatives. (medscape.com)
- Design: 11β-HSD-1 and -2 enzyme activities in abdominal and leg sc adipose tissue were measured by infusing [2,2,4,6,6,12,12-2H7] cortisone (D7 cortisone) and [9,12,12-2H3] cortisol (D3 cortisol) via microdialysis catheters placed in sc fat depots. (elsevier.com)
- Main Outcome Measures: The conversion of infused D7 cortisone to D7 cortisol (via 11β-HSD reductase activity) and D3 cortisol to D3 cortisone (via 11β-HSD dehydrogenase activity) in sc adipose tissue. (elsevier.com)
- D3 cortisone enrichment did not differ in the three cohorts, indicating that 11β-HSD-2 enzyme activity (conversion of cortisol to cortisone) occurs equally in all groups. (elsevier.com)
- However, D7 cortisol enrichment was detectable in abdominal sc fat of overweight/obese participants with type 2 diabetes mellitus only, implying 11β-HSD-1 reductase activity (conversion of cortisone to cortisol) occurs in obese subjects with type 2 diabetes. (elsevier.com)
- Conclusions: There is conversion of cortisone to cortisol via the 11β-HSD-1 enzyme pathway in abdominal sc fat depots in overweight/obese participants with type 2 diabetes mellitus. (elsevier.com)
- It has been suggested for humans and rodents that the placental enzyme, a biological catalyst, 11beta-hydroxysteroid dehydrogenase (11B-HSD) converts biologically active cortisol to an inactive steroid, cortisone. (usda.gov)
- Reduced nicotinamide adenine dinucleotide phosphate is a necessary cofactor for the reductase activity of 11β-hydroxysteroid dehydrogenase type 1 (EC 1.1.1.146), which converts hormonally inactive cortisone to active cortisol (in rodents, 11-dehydrocorticosterone to corticosterone). (elsevier.com)
Inhibitors2
- 3 (1) : vdab099 Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma. (genetex.com)
- This observation has significant implications for developing tissue-specific 11β-HSD-1 inhibitors in type 2 diabetes mellitus. (elsevier.com)
Hexose-6-phosphate dehydrogenase3
- Relationship of 11ß-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase gene polymorphisms with metabolic syndrome and type 2 diabetes. (cdc.gov)
- Hexose-6-phosphate dehydrogenase (EC 1.1.1.47) catalyzes the conversion of glucose 6-phosphate to 6-phosphogluconolactone within the lumen of the endoplasmic reticulum, thereby generating reduced nicotinamide adenine dinucleotide phosphate. (elsevier.com)
- Mice with targeted inactivation of hexose-6-phosphate dehydrogenase lack 11β-hydroxysteroid dehydrogenase type 1 reductase activity, whereas dehydrogenase activity (corticosterone to 11- dehydrocorticosterone) is increased. (elsevier.com)
ELISA Kit1
- Description: A sandwich ELISA kit for detection of Free Fatty Acid Receptor 1 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. (hiv-pharmacogenomics.org)
Metabolism6
- The induction of leptin and 11beta-HSD2 in the syncytiotrophoblast by CRH might promote fetal nutrient supply and placental corticosteroid metabolism in the phase before labour induction. (biomedcentral.com)
- Journal of Clinical Endocrinology and Metabolism , 100 (1), E70-E76. (elsevier.com)
- In terms of tissue-specific cortisol metabolism, it is said that the enzyme 11 beta - hydroxysteroid dehydrogenase type 1 (11B-HSD1) is relevant in HPA axis activity, regenerating active cortisol from its inactive forms intracellularly. (mindbodyfunctionalmedicine.com)
- She then undertook her research fellowship with Profs Robert Sherwin and Bill Tamborlane, learning techniques for investigating human metabolism, studying changes in insulin sensitivity in childhood and adolescence and starting her life-long interest in the issues of hypoglycaemia in type 1 diabetes treatments. (insulin100.com)
- In the tetrapods the two CRs have diverged in function, with MR playing a principal role in the control of mineral balance and GR being predominantly involved in glucose metabolism and immune function [ 10 , 11 ]. (biomedcentral.com)
- 41 Research have demonstrated that some mycotoxins intrude with the performance of the 17-beta-hydroxysteroid dehydrogenase class of enzymes, 11 that are required for correct androgenic metabolism, together with testosterone manufacturing. (feelhealthyagain.net)
Short-chain dehydrogenases1
- It belongs to the family of short-chain dehydrogenases. (wikipedia.org)
Steroid2
- DHEA-S is a C-19 (19 carbon atoms) steroid hormones and 1 of 3 androgens (DHEA, DHEAS, androstenedione) secreted by the adrenal gland. (medscape.com)
- a protein superfamily that includes receptors for estrogens (ER), progestins (PR), and androgens (AR), as well as the corticosteroid receptors (CRs), which in turn comprise the glucocorticoid (GR) and mineralocorticoid receptors (MR). The ancestral steroid receptor is believed to have resembled an ER [ 1 ]. (biomedcentral.com)
Inhibits1
- It seemed that one answer would be a topical lotion that inhibits the A-2 receptor or blocks phosphodiesterase (1). (tim.blog)
Inhibition2
- 29 (1) : 3 Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. (genetex.com)
- Table1)1) is involved in proliferation inhibition of acute myeloid leukemia mediated by Maesopsin 4-O-beta-D-glucoside a natural compound isolated from the leaves of Artocarpus tonkinensis) [21]. (biotech2012.org)
Protein12
- The aim of this study was to explore novel substrate specificities of human 11beta-HSD1, using heterologously expressed protein in the yeast system Pichia pastoris. (ox.ac.uk)
- A second genetic cause of FGD was identified in 15-20% of patients resulting from defects in the MC2R receptor accessory protein ( MRAP ) (FGD type 2) [7] , [8] . (plos.org)
- Estrogen Receptor beta antibody [14C8] detects Estrogen Receptor beta protein at nucleus by immunohistochemical analysis. (genetex.com)
- Description: A sandwich quantitative ELISA assay kit for detection of Human Elongation Of Very Long Chain Fatty Acids Like Protein 1 (ELOVL1) in samples from tissue homogenates, cell lysates or other biological fluids. (operatiebrp.nl)
- Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Elongation Of Very Long Chain Fatty Acids Like Protein 1 (ELOVL1) in tissue homogenates, cell lysates and other biological fluids. (operatiebrp.nl)
- Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Elongation Of Very Long Chain Fatty Acids Like Protein 1 (ELOVL1) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. (operatiebrp.nl)
- WW domain binding protein 1 like [Sour. (gsea-msigdb.org)
- Intrathecal application route has not yet been investigated for TRIAM in autoimmune diseases of the peripheral nervous system (PNS) although the first sites of inflammation and increase of blood-nerve barrier permeability are the proximal nerve roots, as indicated by the early intrathecal protein increase found in these patients [ 11 , 12 ]. (biomedcentral.com)
- They found elevations in the testosterone and DHT concentrations in the muscle and a particularly significant increase in the levels of 5α-reductase type 1 protein, a protein required to convert testosterone to DHT. (e-pan.org)
- Both endogenous GH and its active protein, Insulin like growth factor-1 (IGF-1) have been found to be at high levels in diabetes, especially in patients. (endocrine-abstracts.org)
- The p53 protein is an important tumor suppressor protein and is mutated in about 50 % of human cancers [ 1 ]. (biomedcentral.com)
- We further validate 2 downstream candidates (oxidative stress-induced growth inhibitor 1) and (X-ray repair cross-complementing protein 5) and evaluate their functional relationship with PEL cell survival/proliferation and chemoresistance respectively. (biotech2012.org)
Glucocorticoid2
- Using the real time-polymerase chain reaction, rabbit CP tissue was found to express levels of 11beta-HSD1, glucocorticoid receptor alpha and serum and glucocorticoid-regulated kinase 1 mRNA comparable to that expressed in rabbit ocular ciliary body, thereby highlighting the similarity between these two tissues. (ox.ac.uk)
- with PbGR2b and PbGR1, the glucocorticoid 11-deoxycortisol was a more potent agonist than cortisol. (biomedcentral.com)
20192
- Published 11 February 2019. (life-science-alliance.org)
- Diabetology & metabolic syndrome 2019 11 78. (cdc.gov)
Obese3
- Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and hence may explain why aspirin improves glycemic control in type 2 diabetes. (wikipedia.org)
- The researchers created a group of transgenic (Tg) mice that overproduce 11 beta HSD-1 in roughly the same quantities previously found in the fatty tissue of obese humans. (annecollins.com)
- Participants: Lean nondiabetic (n = 13), overweight/obese nondiabetic (n = 15), and overweight/ obese participants with type 2 diabetes mellitus (n = 15) participated in the study. (elsevier.com)
Testosterone4
- Week 1-12: Test Cypionate association of endogenous testosterone know as much as possible because steroids do have all kinds of impact on the body. (enids.net)
- Dehydroepiandrosterone (DHEA), a well-known precursor of sex hormones, is metabolized to testosterone through the activity of 17β-hydroxysteroid dehydrogenase, a sex-hormone-synthesizing hormone. (e-pan.org)
- Testosterone is converted to dihydrotestosterone (DHT) as a result of elevated 5α-reductase expression (typically SRD5A1 and SRD5A2) 1 , 2 . (e-pan.org)
- DNA information is delivered to the nucleus as testosterone and DHT binds to androgen receptors, based on which essential proteins are produced 1 , 2 . (e-pan.org)
Corticosteroids1
- Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. (ox.ac.uk)
Isozyme2
- Besides this important endocrinological property, the type 1 isozyme (11beta-HSD1) mediates reductive phase I reactions of several carbonyl group bearing xenobiotics, including drugs, insecticides and carcinogens. (ox.ac.uk)
- Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase, Mune T. Rogerson FM. (childrens.com)
Enzymes3
- Context: The role of 11β-hydroxysteroid dehydrogenase types 1 (11β-HSD-1) and 2 (11β-HSD-2) enzymes in sc adipose tissue is controversial. (elsevier.com)
- Objective: The objective of the study was to determine the activity of 11β-HSD-1 and -2 enzymes in the abdominal and leg sc adipose tissue in obesity and diabetes. (elsevier.com)
- Sebocytes contain androgen-metabolizing enzymes, including 5-alpha-reductase type I, 3-beta-hydroxysteroid dehydrogenase, and 17-beta-hydroxysteroid dehydrogenase type II. (medscape.com)
Kidney2
- Among these promising pharmacotherapies are agents that target the kidney, liver, and pancreas as a significant focus of treatment in type 2 diabetes. (ahdbonline.com)
- [ 1 ] Chronic kidney disease alone generally will not cause hyperkalemia until the eGFR is less than 20-25 mL/min. (medscape.com)
Genes7
- The expression of the IUGR marker genes leptin and 11beta-hydroxysteroid dehydrogenase 2 (11beta-HSD2) was measured continuously over a period of 72 h. (biomedcentral.com)
- The most important genes controlling the initial phase of gonadal development, identical in females and males, are Wilms' tumor suppressor 1 ( WT1 ) and steroidogenic factor 1 ( SF1 ). (hormones.gr)
- Precise diagnosis of C. innocuum is necessary because of its unique intrinsic resistance to vancomycin, presumably caused by the presence of 2 chromosomal genes that enable the synthesis of a peptidoglycan precursor terminating in serine with low vancomycin affinity ( 9 , 11 ). (cdc.gov)
- Notably BC-1 cells which are also EBV+ had a much higher number of uniquely altered genes than BCBL-1 and Edivoxetine HCl BCP-1. (biotech2012.org)
- Within the common gene set the top 20 upregulated or downregulated candidate genes in SASP-treated BCP-1 BC-1 and BCBL-1 cell-lines are listed in Table ?Table11 and Table ?Table2 2 respectively including gene description and the altered level of transcription in these cell-lines. (biotech2012.org)
- Interestingly we found that the functional role of most genes in PEL pathogenesis have never been reported although some of them have been implicated in other types of malignancies. (biotech2012.org)
- Our results indicated that all the 5 genes (and (Oxidative stress-induced growth inhibitor 1) one of the highly upregulated genes in SASP-treated KSHV+ PEL cells from microarray data to determine its role in SASP-induced cell apoptosis. (biotech2012.org)
CONGENITAL3
- Mutations in the StAR gene were first described in patients with classic congenital lipoid adrenal hyperplasia (CLAH) in which both the adrenals and the gonads seemed to completely lack steroidogenesis [1] . (plos.org)
- Patients with simple virilizing congenital adrenal hyperplasia (CAH), as well as those with CAH and severe virilization, are less likely to have psychosexual disorders than patients with other types of DSD. (nature.com)
- Pathogenesis includes many genetic pathways , most prominent being Wnt-Beta catenin pathway and also association with other diseases such as multiple endocrine neoplasia ( MEN1 and MEN2 ), familial adenomatous polyposis , Beckwith-Wiedemann syndrome , Li-Fraumeni syndrome , Lynch syndrome , von Hippel-Lindau disease , carney Complex / Syndrome , neurofibromatosis type 1 and congenital adrenal hyperplasia . (wikidoc.org)
Mice1
- The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. (mousephenotype.org)
Inhibitor1
- Enzyme assays performed on intact rabbit CP whole tissue explants confirmed predominant 11beta-HSD1 activity, generating cortisol that was inhibited by glycyrrhetinic acid (an 11beta-HSD inhibitor). (ox.ac.uk)
Activity4
- Purified recombinant 11beta-HSD1 mediated oxidative reactions, however, the labile reductive activity component could not be maintained. (ox.ac.uk)
- Coupled with findings from the University of Edinburgh showing a correlation between increased enzyme activity in fat tissue and obesity in human subjects, the findings strongly suggest that the 11 beta HSD-1 enzyme is an exciting pharmaceutical target for the treatment of visceral obesity. (annecollins.com)
- Studies were conducted to determine 1) if 11B-HSD was present in pig placentae, 2) if its activity changed during gestation, and 3) if its activity was related (correlated) to fetal development. (usda.gov)
- Since p53 induces cell death after its activation, significant research efforts are focused on harnessing this activity for tumor therapy, at least for those tumors with wild type p53. (biomedcentral.com)
Corticosterone1
- Acute administration of corticosterone (the endogenous Type I and Type II receptor agonist), or RU28362 (a specific Type II receptor agonist), to adrenalectomized animals induced changes in leukocyte distribution. (newworldencyclopedia.org)
Syndrome7
- FGD has been described as a syndrome secondary to ACTH resistance, and inactivating mutations in the gene encoding melanocortin type 2 receptor ( MC2R ) were the first to be associated with FGD [6] . (plos.org)
- Association between a 11ß-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population. (cdc.gov)
- Metabolic syndrome and related disorders 2013 Dec 11 (6): 397-402. (cdc.gov)
- Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population. (cdc.gov)
- Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. (cdc.gov)
- [ 1 , 2 ] is a group of conditions associated with clinical and biochemical features of Cushing syndrome, but the hypercortisolemia is usually secondary to other factors. (medscape.com)
- reported a NAFLD liver fat score system (NAFLD LFS) which could predict the fat score in liver according to the metabolic syndrome (MS), type 2 diabetes (T2D), fasting insulin, AST and ALT. (researchsquare.com)
Pathways1
- Animal research have demonstrated that mycotoxins are able to altering elements of each Section 1, 12-14 and Section 2 detox pathways. (feelhealthyagain.net)
Receptor7
- Comparisons of their ligand structures indicate that the Δ9,11 modification of the first-in-class drug vamorolone enables it to avoid interaction with a conserved receptor residue (N770/N564), which would otherwise activate transcription factor properties of both receptors. (life-science-alliance.org)
- Non-transfected (-) and transfected (+) 293T whole cell extracts (30 μg) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Estrogen Receptor beta antibody [14C8] (GTX70174) diluted at 1:5000. (genetex.com)
- Various tissue extracts (20 μg) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Estrogen Receptor beta antibody [14C8] (GTX70174) diluted at 1:500. (genetex.com)
- Estrogen Receptor beta stained by Estrogen Receptor beta antibody [14C8] (GTX70174) diluted at 1:200. (genetex.com)
- Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Free Fatty Acid Receptor 1 (FFAR1) in Tissue homogenates, cell lysates and other biological fluids. (hiv-pharmacogenomics.org)
- CD4-CD8- (double negative, DN) cells become CD4+CD8+ (double positive, DP) cells following productive T cell receptor (TCR) beta chain rearrangement. (gsea-msigdb.org)
- In vitro studies in Schwann cell cultures showed an increased expression of IL-1 receptor antagonist and reduced expression of Toll-like receptor 4 after incubation with TRIAM as well as a protective effect of TRIAM against oxidative stress after H 2 O 2 exposure. (biomedcentral.com)
Genetic5
- Genetic testing and molecular biomarkers 0 15 (1-2): 43-9. (cdc.gov)
- 1 The differentiation of the bipotent gonad to an ovary or testis follows and is also under genetic control. (hormones.gr)
- Hence, genetic differences may also be responsible for differentiating the brain into male and female types. (biomedcentral.com)
- While 10% of patients carry single gene mutations that cause PD (monogenic PD), over 90% of patients have no known family history or known genetic cause of their disease (sporadic PD, or sPD) [ 1 ]. (biomedcentral.com)
- Since biology operates under the rule that anything that can go wrong will go wrong, patients have been described with a genetic defect in 11-beta-hydroxysteroid dehydrogenase. (medicine-opera.com)
Gene Expression1
- After CRH stimulation the trophoblast syncytialisation rate was monitored via syncytin-1 gene expression and beta-hCG (beta-human chorionic gonadotropine) ELISA in culture supernatant. (biomedcentral.com)
20181
- Tel.: +1 773 325 2018. (cdc.gov)
Insulin4
- Studies have established that inflammation and excess insulin are the leading cause of type 2 diabetes and the increasing weight issues in global populations. (mindbodyfunctionalmedicine.com)
- Low insulin sensitivity signifies hyperinsulinemia, which is a precursor to type 2 diabetes. (mindbodyfunctionalmedicine.com)
- She worked with Prof Khalida Ismail to work on aspects of mental health in both type 1 and type 2 diabetes and she developed the UK's DAFNE programme, a structured education programme for flexible insulin self-management for adults with type 1 diabetes, which reduced severe hypoglycemia, with colleagues in Sheffield, North Tyneside and Germany. (insulin100.com)
- Whither the Future of Insulin Management in Type 2 Diabetes? (insulin100.com)
Mutations1
- However, only ∼25% of such patients were found to be the carriers of MC2R mutations and have been classified as type 1 FGD [7] . (plos.org)
Vasodilation1
- Histamine (from mast cells), serotonin (from platelets), bradykinin (from the plasma), and platelet-activating factor (from many types of cells) stimulate the endothelium to produce NO causing vasodilation. (oncohemakey.com)
Secretion5
- In the human ocular ciliary epithelium, Na(+) and water secretion is dependent on a novel mediator of ciliary epithelial Na(+) transport, 11beta-HSD type 1 (11beta-HSD1), that generates intraocular cortisol. (ox.ac.uk)
- Expression of 11beta-HSD1 may be fundamental in the regulation of CSF secretion and the local generation of cortisol may represent a pathophysiological mechanism underlying cortisol-dependent neuroendocrine diseases. (ox.ac.uk)
- CRH did not influence the differentiation of isolated trophoblasts into functional syncytium as determined by beta-hCG secretion, albeit inducing syncytin-1 expression. (biomedcentral.com)
- Following syncytialisation, CRH treatment significantly increased leptin and 11beta-HSD2 expression, as well as leptin secretion into culture supernatant after 48 h. (biomedcentral.com)
- While somatotroph activation and glucagon secretion occur in a deferred manner 1, 4 . (medicinabuenosaires.com)
Synthesis1
- 8 reported that prolonged moderate-intensity running leads to elevations in sex hormone synthesis in the skeletal muscles, particularly 5α-reductase type 1 expression and DHT concentration. (e-pan.org)
Endocrine1
- Endocrine journal 2011 58 (11): 949-59. (cdc.gov)
Human5
- Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1. (ox.ac.uk)
- In conclusion, evidence is provided that human 11beta-HSD1 in vitro is involved in phase I reactions of anti-inflammatory non-steroidal drugs like ketoprofen and DFU-lactol. (ox.ac.uk)
- The human gene for 11 beta-hydroxysteroid dehydrogenase. (wikipedia.org)
- Amino acids 1-153 of human ER-beta expressed in E. coli. (genetex.com)
- PDB-4fam: Crystal structure of human 17beta-hydroxysteroid dehydrogenase ty. (pdbj.org)
Males1
- KD topics (10 sub-acute topics: 5 men, 5 females aged 2.0C15.5 years at time of study) and 6 convalescent subjects: 5 males, 1 female, aged 2.4C15.7 years at time of study) were evaluated by echocardiography through the severe admission with 2 and 6 weeks and 12 months following diagnosis. (forgetmenotinitiative.org)